Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Open ; 8(8): e021856, 2018 08 23.
Article in English | MEDLINE | ID: mdl-30139902

ABSTRACT

OBJECTIVES: Compare outcomes in patients with suspected heart failure (HF) and raised natriuretic peptides who are reviewed in a specialist HF clinic in line with National Institute for Health and Care Excellence (NICE) guidelines (compliant group) versus patients who are not reviewed in the clinic (non-compliant group). DESIGN: Retrospective observational study. SETTING: Single large UK district general hospital. PARTICIPANTS: 567 consecutive patients in primary care with raised N-terminal pro-brain natriuretic peptide (NT-pro-BNP) levels (>400 pg/mL) from February to September 2014. INTERVENTIONS: 161 (28%) patients were referred to the specialist HF clinic and 406 (72%) were not. Outcomes were compared between the two groups. OUTCOME MEASURES: All-cause and cardiovascular (CV) hospitalisations and all-cause mortality. RESULTS: The compliant group were slightly younger than the non-compliant group (78±9 vs 80±9; p=0.019) but had much higher NT-pro-BNP (3108±4526 vs 2271±3637 pg/mL; p<0.0001). Despite this, over a mean follow-up period of 9±2 months, rates of all-cause hospitalisation (24% vs 44%; p<0.0001) and CV hospitalisation (3% vs 15%, p<0.0001) were significantly lower in the compliant group versus the non-compliant group, respectively. There was no significant difference in mortality rates (6% compliant group vs 8% non-compliant group; p=0.487). CONCLUSIONS: Hospitalisation rates in patients with suspected HF and raised NT-pro-BNP were extremely high over a relatively short follow-up period. Patients reviewed in a specialist HF clinic had much higher NT-pro-BNP levels, suggesting they were at higher risk of adverse outcomes, yet also had significantly lower rates of all-cause and CV hospitalisation. Our findings support implementation of the relevant NICE guidelines for patients with suspected HF.


Subject(s)
Cardiologists , Guideline Adherence/statistics & numerical data , Heart Failure/epidemiology , Practice Guidelines as Topic , Referral and Consultation/statistics & numerical data , Aged , Aged, 80 and over , Critical Pathways , England/epidemiology , Female , Follow-Up Studies , Heart Failure/blood , Hospitalization/statistics & numerical data , Humans , Male , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Primary Health Care , Retrospective Studies
2.
Acute Med ; 15(5): 30-2, 2016.
Article in English | MEDLINE | ID: mdl-27116585

ABSTRACT

Acute mitral regurgitation (acute MR) is a rare cause of acute respiratory distress, which can present diagnostic challenges. We present the case of a 57 year old man who developed acute shortness of breath subsequently associated with fever, raised white cells and elevated CRP. Chest x-ray revealed unilateral shadowing and he was treated for pneumonia, despite the finding of severe mitral regurgitation on echo. Failure to respond to antibiotic treatment following 3 weeks on ITU led to the consideration of acute MR as the cause of his symptoms and he responded well to diuretics. He subsequently underwent mitral valve repair. The causes and clinical presentations of this condition are discussed.


Subject(s)
Mitral Valve Insufficiency/complications , Mitral Valve Insufficiency/diagnostic imaging , Pneumonia/diagnostic imaging , Respiratory Insufficiency/etiology , Acute Disease , Diagnosis, Differential , Dyspnea/diagnosis , Dyspnea/etiology , Echocardiography/methods , Heart Valve Prosthesis Implantation/methods , Humans , Male , Middle Aged , Mitral Valve Insufficiency/surgery , Pneumonia/complications , Pneumonia/physiopathology , Radiography, Thoracic/methods , Respiratory Insufficiency/diagnosis , Risk Assessment , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...